Research grant award news: Dr. Zoubeidi (PCF Challenge) and Dr. Wyatt (Movember Discovery)

Date Posted: 
2017-10-06

In the last week, two VPC researchers have been awarded grants to fund research projects aimed at improving the treatment prostate cancer.

Dr. Alex Wyatt and his team, including Drs. Kim Chi and Faraz Hach, were awarded a Movember Discovery Grant for their project, "Genomic truncation of the Androgen Receptor in poor-prognosis castration-resistant prostate cancer." Funded by the Movember Foundation, selected by Prostate Cancer Canada, and announced September 28, the winners were chosen based on novel research projects that have the potential to make a significant difference in a number of areas across the spectrum of prostate cancer research.

The Prostate Cancer Foundation (PCF) awarded Dr. Amina Zoubeidi (VPC/UBC) and Dr. Himisha Beltran (Weill Cornell Medical College) a 2017 PCF Challenge Award, for their project "Targeting BRN2 in Neuroendocrine Prostate Cancer". The Challenge Awards support international, cross-disciplinary teams of investigators conducting pioneering research into critical, unmet medical needs in areas that have the highest potential for impacting and extending lives of men with advanced prostate cancer. This year's awardees were annouced on the first day of the PCF Annual Scientic Retreat, October 5.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Movember 2017

Movember 2017

Movember Canada's annual fundraiser for men's health issues, such as prostate cancer, testicular cancer, fitness and mental health, starts November 1st. Visit the  Vancouver Prostate Centre's fundraising page to donate to or join our team.

Employment

Work at the Vancouver Prostate Centre

Monday, January 30, 2017

Dr. Amina Zoubeidi leads identification of gene linked to growth of aggressive neuroendocrine prostate cancer (NEPC)

DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.